Literature DB >> 25324658

Epidermotropic metastatic melanoma clinically resembling agminated spitz nevi.

Hee Joo Kim1, Byoung Joon So1, Min Gun You1, Il-Hwan Kim1.   

Abstract

Herein, we report a 36-year-old Asian male patient who presented with grouped multiple erythematous waxy papules and nodules on his right medial thigh. He had undergone amputation of the right second toe because of a stage IIa malignant melanoma, 3 years previously. At the time of surgery for the primary tumor, right inguinal lymph node dissection revealed no nodal involvement. Three years after the diagnosis of the primary tumor, crops of multiple erythematous papules and nodules developed. Initial histopathologic evaluation of the papules showed nests of small epithelioid cells similar to compound nevi. However, cytologic features, including high mitotic figures, lack of maturation, and some hyperchromatic nuclei suggested metastatic melanoma. In addition to the pathologic findings, the tumors were on the right thigh, which was the same side as the primary malignant melanoma. The patient underwent wide excision of the tumor and split-thickness skin grafting.

Entities:  

Keywords:  Epidermotropic metastatic malignant melanoma

Year:  2014        PMID: 25324658      PMCID: PMC4198593          DOI: 10.5021/ad.2014.26.5.628

Source DB:  PubMed          Journal:  Ann Dermatol        ISSN: 1013-9087            Impact factor:   1.444


  12 in total

1.  Angiotropism in epidermotropic metastatic melanoma: another clue to the diagnosis.

Authors:  Pedram Gerami; Christopher Shea; Mary S Stone
Journal:  Am J Dermatopathol       Date:  2006-10       Impact factor: 1.533

Review 2.  Epidermotropic malignant melanoma: the distinction between metastatic and new primary lesions in the skin.

Authors:  R Jackson
Journal:  Can J Surg       Date:  1984-11       Impact factor: 2.089

Review 3.  Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma.

Authors:  C M Balch; A C Buzaid; S J Soong; M B Atkins; N Cascinelli; D G Coit; I D Fleming; J E Gershenwald; A Houghton; J M Kirkwood; K M McMasters; M F Mihm; D L Morton; D S Reintgen; M I Ross; A Sober; J A Thompson; J F Thompson
Journal:  J Clin Oncol       Date:  2001-08-15       Impact factor: 44.544

Review 4.  Dying dogma: the pathological diagnosis of epidermotropic metastatic malignant melanoma.

Authors:  W L White; M G Hitchcock
Journal:  Semin Diagn Pathol       Date:  1998-08       Impact factor: 3.464

5.  Cutaneous metastases of malignant melanoma: a clinicopathologic study of 192 cases with emphasis on the morphologic spectrum.

Authors:  Jose A Plaza; Carlos Torres-Cabala; Harry Evans; Hafeez A Diwan; Saul Suster; Victor G Prieto
Journal:  Am J Dermatopathol       Date:  2010-04       Impact factor: 1.533

6.  New primary malignant melanoma, epidermotropism and Indian-file arrangement of metastatic tumor cells in a case with intransit metastases of acral type of malignant melanoma.

Authors:  T Kato; T Demitsu; Y Tomita; H Tagami
Journal:  Dermatologica       Date:  1986

7.  Expression of cyclin D1 and p53 protein in various malignant skin tumors.

Authors:  S Inohara; K Kitagawa; Y Kitano
Journal:  Dermatology       Date:  1996       Impact factor: 5.366

8.  Epidermotropic metastatic melanoma. Are the current histologic criteria adequate to differentiate primary from metastatic melanoma?

Authors:  M P Bengoechea-Beeby; A Velasco-Osés; F Mouriño Fernández; M C Reguilón-Rivero; L Remón-Garijo; C Casado-Pérez
Journal:  Cancer       Date:  1993-09-15       Impact factor: 6.860

9.  Current concepts of metastasis in melanoma.

Authors:  Blazej Zbytek; J Andrew Carlson; Jacqueline Granese; Jeffrey Ross; Martin C Mihm; Andrzej Slominski
Journal:  Expert Rev Dermatol       Date:  2008-10

10.  Epidermotropically metastatic malignant melanoma. Differentiating malignant melanoma metastatic to the epidermis from malignant melanoma primary in the epidermis.

Authors:  R Kornberg; M Harris; A B Ackerman
Journal:  Arch Dermatol       Date:  1978-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.